financetom
Business
financetom
/
Business
/
FTX's Bankman-Fried, seeking to avoid jail, denies witness tampering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
FTX's Bankman-Fried, seeking to avoid jail, denies witness tampering
Aug 1, 2023 10:29 PM

Sam Bankman-Fried, the indicted founder of the bankrupt FTX cryptocurrency exchange, on Tuesday said he never meant to intimidate witnesses at his scheduled October fraud trial, and there is no reason to jail him.

In a letter to US District Judge Lewis Kaplan in Manhattan, Bankman-Fried said prosecutors mischaracterized his intentions in giving a New York Times reporter the writings of former romantic partner Caroline Ellison, who is expected to testify against him.

"Mr. Bankman-Fried's contact with the New York Times reporter was not an attempt to intimidate Ms. Ellison or taint the jury pool," his lawyer, Mark Cohen, wrote in the letter. "It was a proper exercise of his rights to make fair comment on an article already in progress."Bankman-Fried, 31, has pleaded not guilty to stealing billions of dollars in FTX customer funds to plug losses at his hedge fund Alameda Research, where Ellison was chief executive.

He has been largely confined to his parents' Palo Alto, California home on $250 million bond since his December 2022 arrest.

Ellison is one of three former members of Bankman-Fried's inner circle who pleaded guilty to fraud charges and agreed to cooperate with the U.S. Attorney's office in Manhattan.

Kaplan barred Bankman-Fried from speaking about the case and asked both sides to submit written arguments about possible jail.

Prosecutors may respond to Bankman-Fried's letter by Thursday. It is not known when Kaplan will rule.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved